InsidersTradesSigma
Total declarations
Company
▲ Purchases (11 ops.)
▼ Sales (1 ops.)
Insider track record
CFODisclosed buys
11
Disclosed sells
1
T+90 hit rate
33%
T+90 mean return
-22.5%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Finley John David, Chief Financial Officer. Officer active across 1 company, notably Palisade Bio, INC.. Aggregated, 31 filings have been recorded. Split: 11 buys · 1 sell. Total volume traded: €340k. History available since 27 August 2021. The latest transaction was disclosed on 7 July 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Finley John David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations31 total
146,798 shares@ US$2.06640.086% mcap43.3% of flowCommon StockSEC:0001493152-26-032559:1
335,167 sharesCommon StockSEC:0001493152-26-032559:0
133 shares@ US$0.700.0000% mcap0.0% of flowCommon StockSEC:0001493152-26-032559:2
13,333 sharesCommon StockSEC:0001493152-26-006831:0
1,622 shares0Common Stock, par value $0.01SEC:0001493152-24-022037:0
1,000 shares@ US$4.814.9% of flowCommon Stock, par value $0.01SEC:0001493152-24-021431:0
Canonical exit: 22 Aug 2024 (T+90)
666 shares@ US$4.97253.4% of flowCommon Stock, par value $0.01SEC:0001493152-24-021045:0
232 shares0Common Stock, par value $0.01SEC:0001493152-24-018282:0
5,558 shares0Common Stock, par value $0.01SEC:0001493152-24-009709:0
3,475 shares0Common Stock, par value $0.01SEC:0001493152-24-005480:0
10,000 shares@ US$0.46924.9% of flowCommon Stock, par value $0.01SEC:0001493152-24-005207:0
Canonical exit: 6 May 2024 (T+90)
10,000 shares@ US$0.5595.7% of flowCommon Stock, par value $0.01SEC:0001493152-24-004566:0
Canonical exit: 30 Apr 2024 (T+90)
1,309 shares0Common Stock, par value $0.01SEC:0001493152-24-001394:0
5,559 shares0Common Stock, par value $0.01SEC:0001493152-23-045474:0
10,000 shares@ US$0.515.2% of flowCommon Stock, par value $0.01SEC:0001493152-23-042663:0
3,475 shares0Common Stock, par value $0.01SEC:0001493152-23-039936:0
1,309 shares0Common Stock, par value $0.01SEC:0001493152-23-036404:0
15,000 shares@ US$0.539211.3% of flowCommon Stock, par value $0.01SEC:0001493152-23-034754:0
Canonical exit: 26 Dec 2023 (T+90)
15,000 shares@ US$0.65510.2% of flowCommon Stock, par value $0.01SEC:0001493152-23-032655:0
Canonical exit: 12 Dec 2023 (T+90)
5,558 shares0Common Stock, par value $0.01SEC:0001493152-23-032505:0
3,475 shares0Common Stock, par value $0.01SEC:0001493152-23-028702:0
1,309 shares0Common Stock, par value $0.01SEC:0001493152-23-023867:0
3,475 shares0Common Stock, par value $0.01SEC:0001493152-23-021308:0
1,309 shares0Common Stock, par value $0.01SEC:0001493152-23-011080:0
19,481.242 shares@ US$0.14373.1% of flowCommon Stock, par value $0.01SEC:0001493152-22-025023:0
Canonical exit: 30 Nov 2022 (T+90)
25 of 31 declarations
About Finley John David
Finley John David is Chief Financial Officer at Palisade Bio, INC. (XNAS), and the 31 filings in the block relate to that company. Across the 31 observed filings, the recent filings cover the period from 2021-08-30 to 2026-07-08, with EUR 74,566 of purchases and EUR 265,031 of sales, and the most common transaction nature is Option exercise.
